IRVINE, Calif. -- (Business Wire)
Khang & Khang LLP (the “Firm”) announces that it is investigating claims
against BioAmber, Inc. (“BioAmber” or the “Company”) (NYSE: BIOA)
concerning possible violations of federal securities laws.
If you purchased shares of BioAmber and want more information, please
contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman
Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by
e-mail at joon@khanglaw.com.
The investigation focuses on claims that BioAmber and certain of its
officers and/or directors violated federal securities laws by making
materially false and/or misleading statements and/or failing to disclose
that a large customer of the Company that was expected to purchase $2.8
million of succinic acid in the fourth quarter of 2016 postponed the
order to 2017; and as a result, the Company’s statements about its
business, operations, and prospects, were materially false and
misleading and/or lacked a reasonable basis at all relevant times.
If you have any questions concerning this notice or your rights, please
contact Joon M. Khang, a prominent litigator for almost two decades, by
telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.
This press release may constitute Attorney Advertising in some
jurisdictions.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170410006222/en/
Contacts:
Khang & Khang LLP
Joon M. Khang, Esq.
Telephone:
949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com
Source: Khang & Khang LLP
© 2024 Canjex Publishing Ltd. All rights reserved.